Safety and efficacy of Siddha management as adjuvant care for COVID-19 patients admitted in a tertiary care hospital - An open-label, proof-of-concept Randomized Controlled Trial

BACKGROUND: COVID-19 resulted in loss of human lives owing to respiratory failure caused by dysregulated immune system. Though many treatments are evaluated, the most appropriate is yet to be established. OBJECTIVE: To determine the safety and efficacy of Siddha add-on therapy in COVID -19 in terms...

Descripción completa

Detalles Bibliográficos
Autores principales: Christian, Gnanaraj Johnson, Meenakumari, Ramasamy, Shanthimalar, Ramalingam, Sankar, Ganesan, Ravichandran, Vadugam Muthusamy, Elansekaran, Selladurai, Ramamurthy, Murugan, Srinivasan, Venkatachalam, Rajalakshmi, Elumalai, Boopathi, Kangusamy, Vennila, Kesavan, Nijavizhi, Mohanasundaram, Shakthi Paargavi, Ambalavanan, Aruldevi, Selvam, Priyanka, Sekaran, Gajalakshmi, Govindasamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086104/
https://www.ncbi.nlm.nih.gov/pubmed/37197717
http://dx.doi.org/10.1016/j.jaim.2023.100706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086104/
https://www.ncbi.nlm.nih.gov/pubmed/37197717
http://dx.doi.org/10.1016/j.jaim.2023.100706

Ejemplares similares